Perimenopause in Adults (Pitta-dominant years, ~16-50)

About Perimenopause in Adults (Pitta-dominant years, ~16-50)

Perimenopause is structural rather than punctual: a four-to-ten year transition that typically opens in the early-to-mid forties and closes twelve months after the final menstrual period. The STRAW+10 staging frames the arc — late reproductive into early perimenopause (subtle cycle-length variability), late perimenopause (skipped cycles, sixty-plus days of amenorrhea), the final menstrual period itself recognizable only in retrospect, then early and late postmenopause.

FSH oscillates rather than rising linearly, which is why single-draw FSH testing misleads. Vasomotor symptoms (hot flashes and night sweats) surface in roughly eighty percent of women, sleep architecture fragments, mood-disorder risk runs two-to-four-fold elevated for depression, cognitive complaints (peri-fog) appear, genitourinary changes emerge, bone-loss accelerates, and the cardiovascular protection of estrogen begins to lift.

Doshic reading places perimenopause as vata rising on the artava-vaha-srotas foundation that pitta built across the reproductive decades; vasomotor heat is pitta manifesting through the unsettling, and ojas gradually thins. Classical aartavakshaya names the depletion.

The HRT decision is patient-specific — NAMS 2022 supports use for symptomatic women under sixty and within ten years of menopause when contraindications are absent. Ayurvedic rasayana work runs alongside, not against, hormone therapy.

Significance

Perimenopause reshapes neurology, metabolism, sleep, mood, cognition, bone, and cardiovascular risk simultaneously — and the cultural framing has lagged the physiology for a generation. Recognizing the transition as years rather than a moment changes the interventions. Vasomotor symptoms respond to HRT, SSRIs/SNRIs, fezolinetant, cognitive-behavioral therapy, and ayurvedic pitta-pacifying work. Sleep disruption commonly involves hygiene work plus the classical brahmi-jatamansi pairing and ashwagandha. Bone loss accelerates in the late transition — weight-bearing exercise and calcium-vitamin-D become structural.

The HRT debate has shifted post-WHI re-analysis; NAMS 2022 supports symptomatic use within the ten-year window.

Shatavari as estrogen-modulating rasayana is central in classical ayurvedic care, alongside dashamoolarishtam, kumaryasava, daily abhyanga, and chandraprabha-vati. The transition is described as calling for active care rather than waiting it out.

Connections

Perimenopause is vata rising on the pitta foundation that built the reproductive decades. Shatavari anchors estrogen-modulating rasayana, ashwagandha addresses the cortisol-sleep axis, and jatamansi softens the vata-driven sleep fragmentation that runs through the late-transition window. Daily abhyanga is the single most reliable vata-pacifying anchor across the years, and anxiety routinely co-presents alongside the vasomotor and sleep picture as the transition deepens.

Further Reading

• Charaka Samhita Chikitsa Sthana ch 30 (Yonivyapad Chikitsa). Ashtanga Hridayam Uttara Sthana ch 34 Guhyaroga Pratishedha. Classical aartavakshaya concept on menstrual-essence depletion. Modern: STRAW+10 reproductive aging staging; NAMS 2022 hormone therapy position statement; SWAN longitudinal cohort findings on the menopausal transition.